Your browser doesn't support javascript.
loading
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.
Ungerleider, Nathan A; Rao, Sonia G; Shahbandi, Ashkan; Yee, Douglas; Niu, Tianhua; Frey, Wesley D; Jackson, James G.
Affiliation
  • Ungerleider NA; Department of Pathology, Tulane School of Medicine, New Orleans, LA, USA.
  • Rao SG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Shahbandi A; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Yee D; Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Niu T; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Frey WD; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Jackson JG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA. jjacks8@tulane.edu.
Breast Cancer Res ; 20(1): 115, 2018 10 01.
Article in En | MEDLINE | ID: mdl-30285883
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States